Pipeline Watch: Phase III Starts With Tirzepatide, Cabozantinib, Pamrevlumab
Executive Summary
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.